Prof. Ralser serves since 2019 as head of the Institute of Biochemistry at the Charité – Universitätsmedizin Berlin, Germany;[1] as well as since 2022 as group leader at the University of Oxford, UK.

He completed his PhD in 2006 at the Max Planck Institute for Molecular Genetics in Berlin, Germany, studying neurodegenerative diseases.

This was followed by a postdoctoral fellowship at the Vrije Universiteit Amsterdam, Netherlands, where he started to explore mass spectrometry.

[7] Key research topics include: During the COVID-19 pandemic the Ralser group developed a proteomics panel assay for the assessment of disease severity and for the prediction of outcome.

The lab found that these proteins can serve as markers: their abundance strongly correlates with COVID-19 severity and outcome.